Rapid genome sequencing has proven itself in the ICU. Data from the first known study in neuro-specific pediatric inpatients suggest it may be just as valuable on the general pediatric floor.
A shorter RT schedule was noninferior to standard-length treatment for reconstruction complications, with no significant differences in locoregional recurrence or RT toxicity.